ICU Mednet(TM) Medication Management Suite 6.1 and 6.21 의 리콜

U.S. Food and Drug Administration에 따르면, 해당 리콜 는 United States 에서 ICU Medical Inc 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    78418
  • 사례 위험등급
    Class 2
  • 사례 연번
    Z-0195-2018
  • 사례 시작날짜
    2017-10-30
  • 사례 상황
    Open, Classified
  • 사례 국가
  • 사례 출처
    USFDA
  • 사례 출처 URL
  • 비고 / 경고
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • 데이터 추가 비고
    Pump, infusion - Product Code FRN
  • 원인
    Issue 1: the mednet meds 6.1 and 6.21 programs, under certain conditions, can change the piggyback medication entry set settings for existing defined medication entries. this includes (a) whether a medication may be piggybacked and (b) whether an infusion may be interrupted by a piggyback. this only occurs when: 1. medication entries are built with the same displayed name and diluent amount and; 2. the piggyback or interruptible settings differ from one cca to another and; 3. the drug library is exported then imported into the mednet meds program. the changed drug library may then be finalized and downloaded to infusers for use in clinical settings. the changes are made without any notice provided to either the mednet meds user (pharmacist) or to the clinician operating the infuser that the piggyback or interruptible settings have been altered. issue 2: the mednet meds 6.1 program, under certain conditions different from those described above in issue 1, can change the piggyback medication entry set settings for existing defined medication entries. this includes (a) whether a medication may be piggybacked and (b) whether an infusion may be interrupted by a piggyback. this only occurs when: 1. the master drug formulary contains medication entries built with the same displayed name and diluent amounts but one is a limited rule set and the other is a full rule set and; 2. the medication entry built as the full rule set has a blank medication amount with the medication units in mg and; 3. both medication entries have different piggyback options set and; 4. the drug library is exported then imported into the mednet meds program. in this case, the piggyback options will be changed during an import of such drug library.
  • 조치
    ICU Medical sent an Urgent : Medical Device Correction letter dated October 30, 2017, Please Inform potential users in your organization of this notification and complete the attached response form and return it to the fax number or e-mail address on the form,even if you do not have the affected product. If you have distributed the product further, notify your accounts that received the product identified above of this notification and ask them to contact Stericycle at 1-855-215-5460 (M-F,8am-5pm ET) to receive a reply form. ICU Medical is committed to patient safety and is focused on providing exceptional product reliability and the highest level of customer satisfaction. Thank you for your prompt support on this important matter. We appreciate your cooperation.

Device

  • 모델명 / 제조번호(시리얼번호)
    All MedNet 6.1 and 6.21 installations
  • 의료기기 분류등급
  • 의료기기 등급
    2
  • 이식된 장치?
    No
  • 유통
    Worldwide Distribution - USA (nationwide) Distribution and to the countries of : Canada, Australia and Philippines
  • 제품 설명
    ICU Mednet(TM) Medication Management Suite 6.1 and 6.21, Product Code/List Numbers: || (a) 16037-64-01; MedNet 6.1 || b) 16037-64-02; MedNet 6.1 || c) 16037-64-03; MedNet 6.1 || d) 16037-64-04; MedNet 6.21 || The ICU Medical MedNet Medication Management Suite (MMS) is intended to facilitate networked communication between MMS compatible computer systems and MedNet compatible infusion pumps. The MMS provides trained healthcare professionals with the capability to send, receive, report, and store information from interfaced external systems, and to configure and edit infusion programming parameters. The MMS is intended to provide a way to automate the programming of infusion parameters, thereby decreasing the amount of manual steps necessary to enter infusion data. All data entry and validation of infusion parameters is performed by a trained healthcare professional according to physician s orders.
  • Manufacturer

Manufacturer

  • 제조사 주소
    ICU Medical Inc, 600 N Field Dr, Lake Forest IL 60045-4835
  • 제조사 모회사 (2017)
  • Source
    USFDA